| Section |
Status |
NHS England |
Name |
| 05.03.01 |
Formulary
|
 |
Abacavir |
| 05.03.01 |
Formulary
|
|
Abacavir/lamivudine Kivexa® |
| 05.03.01 |
Formulary
|
|
Abacavir/lamivudine/zidovudine Tizivir® |
| 11.04 |
Formulary
|
|
Adalimumab/ adalimumab biosimilar Humira®, Imraldi®, Amgevita®) (Ophthalmology |
| 08.02.04 |
Formulary
|
|
Alemtuzumab |
| 10.02 |
Formulary
|
|
Ataluren Translarna® |
| 05.03.01 |
Formulary
|
|
Atazanavir |
| 05.03.01 |
Formulary
|
|
Atazanavir sulfate/cobicistat Evotaz® |
| 08.01.05 |
Formulary
|
|
Avelumab Bavencio® |
| 05.01.09 |
Formulary
|
|
Bedaquiline Sirturo® |
| 05.03.01 |
Restricted Use
|
|
Bictegravir / emtricitabine / tenofovir-alafenamide Biktarvy ® |
| 09.08.01 |
Formulary
|
|
Burosumab Crysvita® |
| 03.04.03 |
Formulary
|
|
C1 esterase inhibitor Cinryze® |
| 03.04.03 |
Formulary
|
|
C1 esterase inhibitor Berinert® |
| 04.08.01 |
Formulary
|
|
Cannabidiol Epidyolex® |
| 10.02 |
Formulary
|
|
Cladribine Mavenclad® |
| 05.03.01 |
Formulary
|
|
Cobicistat Tybost® |
| 03.04.03 |
Formulary
|
|
Conestat alfa Ruconest® |
| 05.03.01 |
Formulary
|
|
Darunavir |
| 05.03.01 |
Formulary
|
|
Darunavir/cobicistat Rezolsta® |
| 05.03.01 |
Formulary
|
|
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate Symtuza® |
| 05.01.09 |
Formulary
|
|
Delamanid Deltyba® |
| 08.01 |
Formulary
|
|
Dexrazoxane Cardioxane® |
| 05.03.01 |
Formulary
|
|
Didanosine |
| 05.03.01 |
Formulary
|
|
Dolutegravir |
| 13.05.03 |
Formulary
|
|
Dupilumab Dupixent®) (dermatology |
| 05.03.01 |
Formulary
|
|
Efavirenz |
| 05.03.01 |
Formulary
|
|
Efavirenz/emtricitabine/tenofovir disoproxil fumarate Atripla® |
| 09.01 |
Formulary
|
|
Efmoroctocog alfa Elocta® |
| 03.07 |
Restricted Use
|
|
Elexacaftor/tezacaftor/ivacaftor Kaftrio® |
| 05.03.01 |
Formulary
|
|
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate Genvoya® |
| 05.03.01 |
Formulary
|
|
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate Stribild® |
| 05.03.01 |
Formulary
|
|
Emtricitabine |
| 05.03.01 |
Formulary
|
|
Emtricitabine/rilpivirine/tenofovir alafenamide fumarate Odefsey® |
| 05.03.01 |
Formulary
|
|
Emtricitabine/rilpivirine/tenofovir disoproxil fumarate Eviplera® |
| 05.03.01 |
Formulary
|
|
Emtricitabine/tenofovir alafenamide fumarate Descovy® |
| 05.03.01 |
Formulary
|
|
Emtricitabine/tenofovir disoproxil fumarate |
| 05.03.01 |
Formulary
|
|
Etravirine |
| 05.03.01 |
Formulary
|
|
Fosamprenavir |
| 03.04.03 |
Formulary
|
|
Icatibant Firazyr® |
| 09.08.01 |
Formulary
|
|
Inotersen Tegsedi® |
| 05.02.01 |
Formulary
|
|
Isavuconazole Cresemba® |
| 03.07 |
Restricted Use
|
|
Ivacaftor Kalydeco® |
| 05.03.01 |
Formulary
|
|
Lamivudine |
| 05.03.01 |
Formulary
|
|
Lamivudine/abacavir/dolutegravir Triumeq® |
| 05.01.12 |
Formulary
|
|
Levofloxacin Quinsair® |
| 05.03.01 |
Formulary
|
|
Lopinavir/ritonavir Kaletra® |
| 03.07 |
Restricted Use
|
|
Lumacaftor/ivacaftor Orkambi® |
| 05.03.01 |
Formulary
|
|
Maraviroc Celsentri® |
| 10.02.02 |
Formulary
|
|
Mexiletine Namuscla® |
| 05.03.01 |
Formulary
|
|
Nevirapine |
| 10.02 |
Formulary
|
|
Nusinersen Spinraza ® |
| 08.01.05 |
Formulary
|
|
Pertuzumab/trastuzumab Phesgo® |
| 05.03.01 |
Formulary
|
|
Raltegravir |
| 05.03 |
Formulary
|
|
Remdesivir Veklury® |
| 05.03.01 |
Formulary
|
|
Rilpivirine hydrochloride |
| 10.02 |
Formulary
|
|
Risdiplam |
| 05.03.01 |
Formulary
|
|
Ritonavir |
| 10.01.03 |
Formulary
|
|
Rituximab/rituximab biosimilar MabThera®, Rixathon®, Truxima®) (Rheumatology & Other |
| 02.11 |
Formulary
|
|
Rurioctocog alfa pegol Adynovi® |
| 08.01.05 |
Formulary
|
|
Ruxolitinib Jakavi® |
| 05.03.01 |
Formulary
|
|
Saquinavir |
| 05.03.01 |
Formulary
|
|
Stavudine |
| 02.14 |
Formulary
|
|
Tafamidis Vyndaqel |
| 08.01.05 |
Formulary
|
|
Temozolomide |
| 05.03.01 |
Formulary
|
|
Tenofovir disoproxil fumarate |
| 03.07 |
Restricted Use
|
|
Tezacaftor/ivacaftor Symkevi® |
| 09.08.01 |
Formulary
|
|
Trientine |
| 02.11 |
Formulary
|
|
Turoctocog alfa pegol Esperoct® |
| 09.01 |
Formulary
|
|
Vonicog alfa Veyvondi® |
| 05.03.01 |
Formulary
|
|
Zidovudine |
| 05.03.01 |
Formulary
|
|
Zidovudine/lamivudine |
